V
Venova Medical
Develops vascular access systems for patients requiring renal replacement therapy
About Venova Medical
Venova Medical, Inc. is a privately held, clinical-stage medical device company founded in 2018 by CEO Erik van der Burg and CMO Dr. Shant Vartanian. The company is focused on addressing the challenges associated with providing optimal and timely vascular access for patients with chronic kidney and end-stage renal diseases who require hemodialysis. Emerging from a residence in Los Gatos, California during the COVID-19 pandemic, the firm has grown to over 10 employees. The business model centers on the development and eventual sale of its proprietary medical device, pending regulatory approvals.
The company's core product is the Velocity™ pAVF System, a technology designed for the percutaneous (through the skin) creation of arteriovenous fistulas (pAVF). A fistula for dialysis is a connection created between an artery and a vein, which is necessary to ensure high blood flow for effective hemodialysis treatment. Traditionally, this requires open surgery. The Velocity™ system offers a minimally invasive alternative, using a needle stick to create the fistula, a procedure that can be performed in an outpatient setting, surgery center, or office. This approach aims to reduce the barriers preventing patients from starting dialysis with the safer AVF procedure, as many currently begin treatment with higher-risk central venous catheters. The system is engineered to provide durable fistula flow, reduce the need for subsequent interventions to help the fistula mature, and ultimately lower healthcare costs.
Venova Medical is actively pursuing regulatory clearance to bring its product to market. The company is conducting clinical trials, including the VENOS-1 and the now fully enrolled VENOS-2 early feasibility study, under an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA). A significant milestone was achieved in September 2024 with the closing of a $30 million Series B financing round. This funding, co-led by Catalyst Health Ventures and a major medical device company, is allocated to further technology development and support the clinical studies required for FDA approval. The company plans to submit an IDE application for a pivotal U.S. trial in the second quarter of 2025.
Source: Dealroom company dataNews
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Sep 2024 | $30M | $120M | ShangBay Capital · Cadence Healthcare Ventures · Aphelion Capital · Mirae Asset Capital | ↗ |
| EARLY VC✓Equity / VC | Oct 2022 | $6.9M | $28M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Venova Medical is 1.8K monthly website visits, up 83.7% over the last three months. Venova Medical's team grew 8.7% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Venova Medical in the Los Gatos ecosystem
The Venova Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
- CVCatalyst Health Ventures
ShangBay Capital
Cadence Healthcare Ventures- ACAphelion Capital
Mirae Asset Capital- KIKOFA Healthcare Investments
Other known investors1 additional known investor
University of California, San Francisco
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Venova Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Venova Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








